This is the authors' abstract. We don't add key points for this paper.
Recent mental health initiatives have called for a shift away from purely report-based conceptualizations of psychopathology toward a biobehaviorally oriented framework. The current work illustrates a measurement-oriented approach to challenges inherent in efforts to integrate biological and behavioral indicators with psychological-report variables. Specifically, we undertook to quantify the construct of inhibitory control (inhibition-disinhibition) as the individual difference dimension tapped by self-report, task-behavioral, and brain response indicators of susceptibility to disinhibitory problems (externalizing proneness). In line with prediction, measures of each type cohered to form domain-specific factors, and these factors loaded in turn onto a cross-domain inhibitory control factor reflecting the variance in common among the domain factors. Cross-domain scores predicted behavioral-performance and brain-response criterion measures as well as clinical problems (i.e., antisocial behaviors and substance abuse). Implications of this new cross-domain model for research on neurobiological mechanisms of inhibitory control and health/performance outcomes associated with this dispositional characteristic are discussed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Venables et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: